Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Hepatitis Drugs Market and its Growth Prospect in the Near FutureThe global hepatitis drugs market was valued at $23,222.1 million in 2014, and it is expected to grow with a CAGR of 29.7% during 2015 - 2020.
By: P&S Intelligence The increasing incidences of various types of hepatitis, such as hepatitis B, and hepatitis C are playing a pivotal role in the growth of the global hepatitis drugs market (https://www.psmarketresearch.com/ Request to Get the Sample Pages at: https://www.psmarketresearch.com/ However, the high capital expenditure and stringent regulatory requirements are inhibiting the growth of the market. The growing number of collaboration and partnerships is one of the latest trends observed in the market. The key companies operating in the global hepatitis drugs market include Gilead Sciences Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., GlaxoSmithKline PLC, AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, and Mitsubishi Tanabe Pharma Corporation. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|